" class="no-js "lang="en-US"> Biopharmaceutical Archives - Medtech Alert
Wednesday, June 19, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

GC Biopharma Receives a Business License for the Construction of a Plasma Fractionation Plant and Technology Transfer in Indonesia

GC Biopharma, a South Korean biopharmaceutical company, has announced that it has successfully obtained final […]

Acurex Biosciences Appoints Esteemed Biopharmaceutical Leader Dr. Robert Booth to its Board of Directors

Acurex Biosciences, a biopharmaceutical company with a mission to stop neurodegeneration before it begins, announces […]

ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

ClearPoint Neuro, a global therapy-enabling platform company providing navigation and delivery to the brain, today […]

Coeptis Therapeutics Appoints Brian Cogley as Chief Financial Officer

Coeptis Therapeutics, a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced today the […]

Malaysian Genomics Inks Expansion Agreement in Bangladesh

Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced a strategic […]

Asahi Kasei Bioprocess America and GeminiBio Enter Strategic Partnership

Asahi Kasei Bioprocess America, a subsidiary of diversified Japanese multinational company Asahi Kasei, and GeminiBio […]

TORL BioTherapeutics Launches with $158 Million Series B Financing to Advance Development of Novel Oncology Biologics

TORL BioTherapeutics, a biopharmaceutical company focused on developing new biologics for cancer treatment, has announced […]

Coeptis Therapeutics Secures Exclusive Rights to Negotiate the Acquisition of Transformational Cell Therapy Platform

Coeptis Therapeutics, a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced it has […]

Sage Therapeutics Appoints Jessica Federer to Board of Directors

Sage Therapeutics, a biopharmaceutical company leading the way to create a world with better brain […]

Personalis Selected for Clinical Research by AstraZeneca After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay

Personalis, a leader in advanced genomics for precision oncology, today announced it will continue its […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more